Retraction notices

ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells

Type

Correction

Notice date

9/1/2010 0:00

Journal

Molecular Cancer Therapeutics

Publisher

American Association for Cancer Research

Notice DOI

10.1158/1535-7163.mct-10-0671

Original paper DOI

10.1158/1535-7163.mct-10-0019

Reasons

• Error in Image
• Investigation by Company/Institution
• Manipulation of Images
• Misconduct - Official Investigation(s) and/or Finding(s)

Matching venue names

Name match only, not an authoritative journal identifier.

• Molecular Cancer Therapeutics